Microbot Medical (NASDAQ:MBOT) Posts Quarterly Earnings Results, Misses Estimates By $0.02 EPS

Microbot Medical (NASDAQ:MBOT) released its earnings results on Wednesday. The biotechnology company reported ($0.20) earnings per share for the quarter, missing the consensus estimate of ($0.18) by ($0.02), Zacks reports.

Microbot Medical Stock Performance

Shares of MBOT opened at $1.53 on Friday. Microbot Medical has a 1 year low of $0.82 and a 1 year high of $3.38. The firm has a fifty day moving average of $1.74 and a 200-day moving average of $1.31. The company has a market cap of $53.16 million, a price-to-earnings ratio of -1.91 and a beta of 1.60.

Analyst Ratings Changes

Separately, HC Wainwright upped their target price on Microbot Medical from $7.00 to $9.00 and gave the company a “buy” rating in a report on Friday, January 24th.

Microbot Medical Company Profile

Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces.